Acadia Healthcare (ACHC) and Tenet Health (THC) on Torvanta's measures: ACHC grades higher on 0 of the 4 factor families and THC on 4.
| ACHC | THC | |
|---|---|---|
| Value grade | n/a | A+ |
| Growth grade | D | B |
| Profitability grade | n/a | A- |
| Momentum grade | C | A- |
| Market value | n/a | $21.5B |
| P/E (trailing) | n/a | 10.3x |
| Forward P/E (Torvanta model estimate) | Subscribers | Subscribers |
| Revenue, last 12 months | $3.4B | $21.8B |
| Revenue growth (y/y) | n/a | +5% |
| Operating margin | 0.0% | 20.8% |
| Return on invested capital | n/a | 149.8% |
| Free-cash-flow yield | n/a | 14.0% |
| Total return, 1 year | +21.2% | +34.2% |
| Total return, 3 years | n/a | n/a |
Full ACHC analysis · Full THC analysis
Acadia Healthcare (ACHC) and Tenet Health (THC) on Torvanta's measures: ACHC grades higher on 0 of the 4 factor families and THC on 4. Which fits an investor depends on their goals; this is research, not a recommendation. Subscribers see where the model ranks each and its expected return.
On trailing earnings ACHC trades at n/a and THC at 10.3x; their value grades are n/a and A+ against their sectors.
Subscribers get a rating, a fair value estimate, a 12-month target and a risk read for every S&P 500 company, Torvanta's earnings estimates, and three model portfolios (Active, Adaptive and Patient) with every trade sized and explained. A free account includes 3 full Stock Analyst reports a month.
See plans Or get the free weekly newsletterTorvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.
All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer